Ekaterina Zaharieva, EU Commissioner for Start-ups, Research and Innovation, paid a two-day working visit to the Netherlands this week. During the visit, the focus was on the important role of research and innovation in strengthening Europe’s competitiveness. On the first…
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency disorder. The resubmission of the supplemental New Drug Application (sNDA) seeks approval for dosages…
An independent review committee has unanimously selected three projects to receive a grant from the Prof. Andrea Evers Fund for Health, Behaviour and Society. The fund, which was launched earlier this year, supports innovative inter- and transdisciplinary research in health…
The Dutch technology industry is once again demonstrating the power of innovation: developing solutions that contribute to the future of Europe and the world. With its groundbreaking battery technology, LeydenJar has won the Peter Wennink Tech Award 2026. Through the…
Leiden, the Netherlands, May 26th 2026 – VitroScan, a biotechnology company pioneering predictive ex vivo tumor testing, today announced the start of a joint project with scientists from the Radboudumc to advance the development of novel cell therapies for the treatment of ovarian cancer. Ovarian cancer…
LUMC and NecstGen are strengthening their development and production facilities for cell and gene therapy by bringing everything together under one roof within LUMC. The strengths of both organizations will be combined, preserving the best of both and allowing them…
On the evening of 6 May, a patient with a hantavirus infection was admitted to LUMC. Admission and care have proceeded as planned. Hantavirus confirmed It has been confirmed that the admitted patient has hantavirus. The patient has been informed…
For 125 years, Leiden University and the Leidse Instrumentmakers School (LiS) have worked together at the intersection of science and technology. Today, that collaboration is more relevant than ever, as the demand for highly skilled high-tech professionals continues to grow…
Around forty microscopes, several culture laboratories, and some 15,000 zebrafish: that is the workplace of Sylvia le Dévédec. She is one of the managers of the Leiden Cell Observatory, a unique facility that is open to all researchers. Le Dévédec…
Companies at Leiden Bio Science Park attracted around €350 million in venture capital in 2025. That is significantly more than in previous years. This is according to research by real estate advisor CBRE. Venture capital is money invested in new…
On 3 April 2026, RED Company submitted the permit application for the construction of Lilly’s production facility to the Municipality of Katwijk. To demonstrate that the development is feasible and complies with all applicable laws and regulations, RED Company has…
Patients with advanced cancer for whom standard treatments no longer work may benefit from off-label medicines: approved drugs that are used for a different disease than the one for which they are officially registered. This means a larger group of…